Clinical Research Investigating Alzheimer's Disease in China: Current Status and Future Perspectives Toward Prevention

Q Wang; F Gao; L N Dai; J Zhang; D Bi; Y Shen

doi:10.14283/jpad.2022.46

Clinical Research Investigating Alzheimer's Disease in China: Current Status and Future Perspectives Toward Prevention

J Prev Alzheimers Dis. 2022;9(3):532-541. doi: 10.14283/jpad.2022.46.

Authors

Q Wang¹, F Gao, L N Dai, J Zhang, D Bi, Y Shen

Affiliation

¹ Yong Shen, Department of Neurology and Institute on Aging and Brain Disorders, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China; Neurodegenerative Disorder Research Center, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China, E-mail: yongshen@ustc.edu.cn.

PMID: 35841254
DOI: 10.14283/jpad.2022.46

Abstract

Based on the background of research investigating brain aging and neurodegenerative diseases in China, the present review addresses Alzheimer's disease (AD), one of the most common types of neurodegenerative diseases, clinical research progress, and prospects for future development in China.

Keywords: Alzheimer’s disease; China; biomarkers; clinical trials.

Publication types

Review
Research Support, Non-U.S. Gov't

MeSH terms

Aging
Alzheimer Disease* / diagnosis
Alzheimer Disease* / epidemiology
Alzheimer Disease* / prevention & control
Biomarkers
Brain
Humans
Neurodegenerative Diseases*

Substances

Biomarkers